{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:17:40Z","timestamp":1788632260403,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/phm.0b013e31817c115b","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T13:06:31Z","timestamp":1236258391000},"page":"556-566","source":"Crossref","is-referenced-by-count":29,"title":["Safety Profile of Multilevel Chemical Denervation Procedures Using Phenol or Botulinum Toxin or Both in a Pediatric Population"],"prefix":"10.1097","volume":"87","author":[{"given":"Kat","family":"Kolaski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Ajizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath","family":"Pasutharnchat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Andrew","family":"Koman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 5","key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.","volume":"8","author":"Aoki","year":"2001","journal-title":"Eur J Neurol"},{"key":"R2-5-20210202","first-page":"13","article-title":"Pharmacology of phenol in peripheral nerve blocks: a review.","volume":"55","author":"Felsenthal","year":"1974","journal-title":"Arch Phys Med Rehabil"},{"key":"R3-5-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(78)90009-X","article-title":"Use of phenol as a neurolytic agent: a review.","volume":"5","author":"Wood","year":"1957","journal-title":"Pain"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3928\/0147-7447-19950201-14","article-title":"Treatment of acquired muscle spasticity using phenol peripheral nerve blocks.","volume":"18","author":"Botte","year":"1995","journal-title":"Orthopedics"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-8749.1997.tb07408.x","article-title":"Botulinum toxin A in the hemiplegic upper limb: a double-blind trial.","volume":"39","author":"Corry","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"R6-5-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0966-6362(99)00012-0","article-title":"Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.","volume":"10","author":"Sutherland","year":"1999","journal-title":"Gait Posture"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.83.6.481","article-title":"Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.","volume":"83","author":"Ubhi","year":"2000","journal-title":"Arch Dis Child"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01241398-200001000-00022","article-title":"Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.","volume":"20","author":"Koman","year":"2000","journal-title":"J Pediatr Orthop"},{"key":"R9-5-20210202","first-page":"659","article-title":"Phenol motor point block in the management of muscular hypertonia.","volume":"47","author":"Halpern","year":"1966","journal-title":"Arch Phys Med Rehabil"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jama.1967.03120260051008","article-title":"Peripheral nerve block with phenol in the management of spasticity. Indications and complications.","volume":"200","author":"Khalili","year":"1967","journal-title":"JAMA"},{"key":"R11-5-20210202","first-page":"20","article-title":"Treatment of spasticity in cerebral palsy by means of phenol nerve block of peripheral nerves.","volume":"16","author":"Helwig-Larsen","year":"1969","journal-title":"Dan Med Bull"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1469-8749.1971.tb03241.x","article-title":"Management of spasticity in cerebral palsied children by peripheral nerve block with phenol.","volume":"13","author":"Spira","year":"1971","journal-title":"Dev Med Child Neurol"},{"key":"R13-5-20210202","first-page":"155","article-title":"Intramuscular neurolysis for spasticity in children.","volume":"60","author":"Easton","year":"1979","journal-title":"Arch Phys Med Rehabil"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02752218","article-title":"Phenol block in the management of spastic cerebral palsy.","volume":"61","author":"Yadav","year":"1994","journal-title":"Indian J Pediatr"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.apmr.2003.09.032","article-title":"Combining botulinum toxin and phenol to manage spasticity in children.","volume":"85","author":"Gooch","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.PHM.0000118038.02326.CA","article-title":"Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.","volume":"83","author":"Wong","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00002018-200629010-00003","article-title":"Botulinum toxin treatment of adult spasticity: a benefit-risk assessment.","volume":"29","author":"Sheean","year":"2006","journal-title":"Drug Saf"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/(SICI)1097-4598(1997)6+<61::AID-MUS6>3.0.CO;2-H","article-title":"Traditional pharmacological treatments for spasticity. Part I: Local treatments.","volume":"6","author":"Gracies","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00001199-199902000-00013","article-title":"Management of spasticity in children. Part I. Chemical denervation.","volume":"14","author":"Gormley","year":"1999","journal-title":"J Head Trauma Rehabil"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/ptj\/80.10.974","article-title":"Validation of a model of gross motor function for children with cerebral palsy.","volume":"80","author":"Palisano","year":"2000","journal-title":"Phys Ther"},{"key":"R21-5-20210202","first-page":"1040","article-title":"Phenol block for hip flexor muscle spasticity under ultrasonic monitoring.","volume":"73","author":"Koyama","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"R22-5-20210202","first-page":"227","article-title":"The Practical Management of Spasticity in Children and Adults.","author":"Glenn","year":"1990"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/apmr.2001.21975","article-title":"Phenol block of peripheral nerve conduction: titrating for optimum effect.","volume":"82","author":"Sung","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1542\/peds.2006-0313","article-title":"Incidence and nature of adverse events during pediatric sedation\/anesthesia for procedures outside the operating room: report from the Pediatric Sedation Research Consortium.","volume":"118","author":"Cravero","year":"2006","journal-title":"Pediatrics"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000542-199108000-00027","article-title":"Phenol motor point blocks in children: plasma concentrations and cardiac dysrhythmias.","volume":"75","author":"Morrison","year":"1991","journal-title":"Anesthesiology"},{"key":"R26-5-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(84)80071-2","article-title":"Ventricular arrhythmias and mitral valve prolapse in childhood.","volume":"105","author":"Kavey","year":"1984","journal-title":"J Pediatr"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1542\/peds.2006-2780","article-title":"Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures: an update.","volume":"118","author":"Cote","year":"2006","journal-title":"Pediatrics"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2044.2000.01065.x","article-title":"Anaesthesia and pain management in cerebral palsy.","volume":"55","author":"Nolan","year":"2000","journal-title":"Anaesthesia"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1460-9592.2002.00635.x","article-title":"Cerebral palsy and anaesthesia.","volume":"12","author":"Wongprasartsuk","year":"2002","journal-title":"Paediatr Anaesth"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2310\/7010.2006.00041","article-title":"Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity.","volume":"21","author":"Goldstein","year":"2006","journal-title":"J Child Neurol"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1469-8749.2007.00818.x","article-title":"High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy.","volume":"49","author":"Willis","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/mds.21097","article-title":"When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy.","volume":"21","author":"Heinen","year":"2006","journal-title":"Mov Disord"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1017\/S0012162201000445","article-title":"Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity.","volume":"43","author":"Bakheit","year":"2001","journal-title":"Dev Med Child Neurol"},{"issue":"suppl 9","key":"R35-5-20210202","first-page":"S398","article-title":"A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox) and botulinum toxin, type B (Myobloc) on systemic and ocular autonomic symptoms and physiology in patients with cervical dystonia.","volume":"19","author":"Tintner","year":"2004","journal-title":"Mov Disord"},{"key":"R36-5-20210202","first-page":"554","article-title":"Phenol block for control of hip flexor and adductor spasticity.","volume":"53","author":"Awad","year":"1972","journal-title":"Arch Phys Med Rehabil"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0012162201211426","article-title":"Adverse events following repeated injections with botulinum toxin A in children with spasticity.","volume":"43","author":"Mohamed","year":"2001","journal-title":"Dev Med Child Neurol"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002060-200807000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:38:32Z","timestamp":1786037912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002060-200807000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0b013e31817c115b","relation":{},"ISSN":["0894-9115"],"issn-type":[{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}